Trial Details
COMPLETEDBasic Information
| Clinical ID | c1365 |
|---|---|
| Identifier | NCT00073021 |
| Trial Title | Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Asacol 800 mg (mesalamine)|DRUG: Asacol 400 mg (mesalamine) |
Participant Information
| Sponsor | Warner Chilcott |
|---|---|
| City | Scottsdale |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2000-09-01 |
|---|---|
| Primary Completion Date | 2025-09-03 |
| Completion Date | 2025-09-03 |